Comparative Analysis of Transduced Primary Human Dendritic Cells Generated by the Use of Three Different Lentiviral Vector Systems

被引:11
作者
Grabski, Elena [1 ]
Waibler, Zoe [2 ]
Schuele, Silke [3 ]
Kloke, Bjoern-Philipp [3 ]
Sender, Linda Y. [1 ,4 ]
Panitz, Sylvia [3 ]
Cichutek, Klaus [3 ]
Schweizer, Matthias [3 ]
Kalinke, Ulrich [1 ,4 ]
机构
[1] TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Infect Res, D-30625 Hannover, Germany
[2] Paul Ehrlich Inst, Jr Res Grp NG2, D-63225 Langen, Germany
[3] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany
[4] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany
关键词
Human dendritic cells; Transduction efficiency; Lentiviral vectors; Immune function; SIMIAN IMMUNODEFICIENCY VIRUS;
D O I
10.1007/s12033-010-9340-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lentiviral gene transfer vectors are suitable for genetically modifying non-cycling primary human cells. In this study, we analyzed transduced human dendritic cells (DC) generated by the use of three different GFP-encoding lentiviral vectors, HIV-2 ROD A Delta env-GFP (ROD A), SIVsmm PBj Delta E EGFP (PBj), and SIVmac DE EGFP (SIVmac). CD14(+) monocytes were isolated from buffy coat, transduced, and differentiated to immature and mature DC. Cytofluometric analysis of DC revealed high transduction efficiencies at MOI 1 for simian immunodeficiency virus (SIV)-derived vectors PBj and SIVmac ranging between 80-90 and 70-90%, respectively. In contrast, transduction with ROD A resulted only in approximately 30%-positive DC at the same MOI. Of note, none of the analyzed vectors affected expression of maturation and/or activation markers. Moreover, transduction with PBj or SIVmac did not induce significant cytokine responses whereas ROD A transduction stimulated weak interferon-alpha responses. SIVmac transduced DC showed normal phagocytosis of antigen and normal allo T cell stimulatory capacity when compared with untreated DC. Thus, the SIVmac lentiviral transduction vector is suitable for efficient genetic modification of human DC without affecting phenotype or function and thus qualifies this vector as a versatile tool for use in basic research.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 15 条
[1]   Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination [J].
Chinnasamy, N ;
Treisman, JS ;
Oaks, MK ;
Hanson, JP ;
Chinnasamy, D .
GENE THERAPY, 2005, 12 (03) :259-271
[2]   Lentiviruses in gene therapy clinical research [J].
Connolly, JB .
GENE THERAPY, 2002, 9 (24) :1730-1734
[3]   Characterization of Simian Immunodeficiency Virus SIVSM/Human Immunodeficiency Virus Type 2 Vpx Function in Human Myeloid Cells [J].
Goujon, Caroline ;
Arfi, Vanessa ;
Pertel, Thomas ;
Luban, Jeremy ;
Lienard, Julia ;
Rigal, Dominique ;
Darlix, Jean-Luc ;
Cimarelli, Andrea .
JOURNAL OF VIROLOGY, 2008, 82 (24) :12335-12345
[4]   Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro [J].
Gruber, A ;
Kan-Mitchell, J ;
Kuhen, KL ;
Mukai, T ;
Wong-Staal, F .
BLOOD, 2000, 96 (04) :1327-1333
[5]   Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity [J].
Jonuleit, H ;
Tüting, T ;
Steitz, J ;
Brück, J ;
Giesecke, A ;
Steinbrink, K ;
Knop, J ;
Enk, AH .
GENE THERAPY, 2000, 7 (03) :249-254
[6]   Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions [J].
Jonuleit, H ;
Kühn, U ;
Müller, G ;
Steinbrink, K ;
Paragnik, L ;
Schmitt, E ;
Knop, J ;
Enk, AH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3135-3142
[7]   CD40 LIGAND-INDEPENDENT B-CELL ACTIVATION REVEALED BY CD40 LIGAND-DEFICIENT T-CELL CLONES - EVIDENCE FOR DISTINCT ACTIVATION REQUIREMENTS FOR ANTIBODY-FORMATION AND B-CELL PROLIFERATION [J].
LANE, P ;
BURDET, C ;
MCCONNELL, F ;
LANZAVECCHIA, A ;
PADOVAN, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1788-1793
[8]   Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain [J].
Liehl, B. ;
Hlavaty, J. ;
Moldzio, R. ;
Tonar, Z. ;
Unger, H. ;
Salmons, B. ;
Guenzburg, W. H. ;
Renner, M. .
GENE THERAPY, 2007, 14 (18) :1330-1343
[9]   α-type-1 polarized dendritic cells:: A novel immunization tool with optimized CTL-inducing activity [J].
Mailliard, RB ;
Wankowicz-Kalinska, A ;
Cai, Q ;
Wesa, A ;
Hilkens, CM ;
Kapsenberg, ML ;
Kirkwood, JM ;
Storkus, WJ ;
Kalinski, P .
CANCER RESEARCH, 2004, 64 (17) :5934-5937
[10]   Stable transduction of primary human monocytes by simian lentiviral vector PBj [J].
Mühlebach, MD ;
Wolfrum, N ;
Schüle, S ;
Tschulena, U ;
Sanzenbacher, R ;
Flory, E ;
Cichutek, K ;
Schweizer, M .
MOLECULAR THERAPY, 2005, 12 (06) :1206-1216